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Breast edemaAbstract Introduction: Breast edema can be caused by a variety of pathologic processes of benign
or malignant diseases. Contrast enhanced digital mammogram (CEDM) has been shown to
improve the probability of malignancy detection when compared with the conventional mammog-
raphy alone.
Patients and methods: This study was prospectively carried on 34 female patients with breast edema
at the female imaging unit of the Radiology Department. The age range was 29–80 years. Bilateral
conventional mammography (MX) and contrast-enhanced digital mammographic procedure
(CEDM) were performed in approximately 7–10 min and followed by complementary ultrasound
(US).
Results: As regards enhancement patterns in our study, noncontrast uptake and diffuse parenchy-
mal uptake were considered as benign and intense contrast uptake is considered malignant and ring
enhancement in keeping with both benign and malignant lesions.
The calculated sensitivity and speciﬁcity of dual energy contrast enhanced digital mammography
were 95%, and 73% respectively, with a positive predictive value (PPV) of 88% and negative pre-
dictive value (NPV) of 88%.
Conclusion: Dual-energy contrast-enhanced digital mammography is a useful technique in identi-
ﬁcation of lesions in mammographically dense edematous breasts and proved to be a useful tool in
the follow-up of cases presenting by edema after conservative breast surgery and chemotherapy.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The accuracy of mammography is limited in dense breasts
where surrounding ﬁbroglandular tissue decreases theconspicuity of lesions. Even when tumors are detected, the full
extent of disease may not be clearly depicted. The primary and
metastatic potential of tumors can be directly linked to angio-
genesis. Growth beyond a few millimeters in diameter requires
the formation of new blood vessels to supply the oxygen and
nutrients necessary for survival (1). Tumor angiogenesis fac-
tors stimulate formation of abnormal vessels that leak and
shunt blood. Therefore, imaging methods with contrast
812 N.A.E. ElSaid et al.medium potentially can aid in the detection and diagnosis of
cancer (1).
Breast edema can be caused by a variety of pathologic pro-
cesses of benign or malignant diseases. It may occur with
inﬂammatory breast carcinoma, lymphatic obstruction, masti-
tis, lymphoma, post-radiation changes or systemic conditions
such as congestive heart failure and nephritic syndrome (1).
The mammographic ﬁndings of breast edema are skin
thickening and increased parenchymal density with prominent
interstitial markings.
On ultrasonography, it presents as marked skin thickening
and increased echogenicity of the subcutaneous fat layer with a
reticular anechoic structure, which is suggestive of dilated lym-
phatics (1).
CEDM has been shown to improve the probability of
malignancy detection when compared with the conventional
mammography alone. CEDM is a useful adjunct to diagnostic
mammography and a promising problem-solving tool (2).
Despite the overlap between post treatment changes and
tumor recurrence, the two entities can usually be distinguished
by the characteristic mammographic appearances of post treat-
ment sequelae and by comparing interval ﬁndings on successive
studies. Postoperativemasses and ﬂuid collections slowly dimin-
ish in size and usually resolve by 1 year after surgery. Radiation-
induced edema gradually resolves; increasing edemamay be due
to recurrent cancer. Postsurgical scarring usually appears as a
poorly marginated soft-tissue mass with interspersed radiolu-
cent areas. Recurrent cancer is usually seen as a mass with no
central radiolucent areas. Pleomorphic and granularmicrocalci-
ﬁcations are important markers for recurrent cancer and can
usually be distinguished from the thick, calciﬁed plaques and
elongated dystrophic calciﬁcations associated with scarring.
2. Patients and methods
2.1. Patients
This study was prospectively carried on 34 female patients with
breast edema (1) at our female imaging unit. Patients were
referred from the outpatient clinics of the internal medicine,
surgery and radiotherapy departments. The age range was
29–80 years.
Comprehensive explanations of the procedures were pro-
vided for all cases, including the associated risks and con-
traindications. They agreed with a written consent to
undergo the contrast-enhanced digital mammographic exami-
nation after performing renal function tests.
The study has been approved by the institutional board.
Inclusion Criteria: 1. Patients presenting by unilateral or
bilateral breast edema on conventional imaging (conventional
mammography and ultrasound) warranting detection and
characterization of breast lesions. 2. Patients who had under-
gone conservative breast surgery or chemotherapy with newly
developed breast edema with suspected residual or recurrent
pathology.
Exclusion Criteria: (1) The early post-operative cases or
recently treated with radio-therapy, so as to minimize false
positive results. (2) Contraindication to IV contrasts material
injection, such as: Allergic patients or those known to have his-
tory of complications from contrast media such as anaphylac-
tic reaction. (3) Patients with renal failure. (4) Patients with
bad general condition. (5) Pregnant females.All patients were submitted to the following:
I Clinical history: Full history taking including clinical
presentation (complaint), age, family and past medical
history.
II Mammographic, ultrasound and CEDM examination.
III Pathologic diagnosis: Analysis of obtained biopsies
whether by ﬁne-needle aspiration cytology, needle
biopsy, excisional biopsy, or by radical surgery, all of
which were diagnosed by experienced pathologists in
the analysis of breast cancer.
2.2. Contrast agent
The contrast agent used was the nonionic solution (iohexol,
Omnipaque 300; Nycomed, Roskilde, Denmark) containing
300 mg of iodine per milliliter, which is commonly used for
CT. In our study,we injected 1.5 ml/kg of the agent by hand over
a period of approximately 1 min with a maximum of 120 ml.
2.3. Instrumentation
All images were acquired with a production system
(Senobright; GE Medical Systems, Milwaukee, Wis). GE
Healthcare’s new SenoBright Contrast Enhanced Spectral
Mammography (CESM) technology was designed to allow
the physician to image blood ﬂow through angiography of
the breast using a contrast agent and a dual energy acquisition
technique.
2.4. Technique
This consisted of high-energy and low-energy digital mammo-
grams obtained after administration of iodinated contrast
agent.
Here, the nonionic iodine contrast agent was injected
between pre and postcontrast image acquisitions in which
the X-ray beam is produced at a relatively high energy, above
the K-edge of iodine. The images were subtracted, canceling
the soft-tissue contrast that is common to the two images
and isolating the iodine signal in the region of angiogenesis.
At ﬁrst bilateral conventional mammography both cranio-
caudal and medio-lateral oblique views were taken. Then typ-
ically, the contrast-enhanced digital mammographic procedure
was performed in approximately 7–10 min. This included
3 min for placement of the intravenous catheter and contrast
injection, 1 min for obtaining the cranio-caudal image for the
normal breast, and 3–6 min for acquisition of the rest of
images (the cranio-caudal and the medio-lateral oblique pro-
jections for the abnormal breast) followed by the medio-
lateral oblique view of the normal side.
Finally, the lesions were analyzed by three specialized radi-
ologists for the presence, morphology, and pattern of
enhancement.
2.5. Statistics
Using the standard of reference, sensitivity, speciﬁcity, and
accuracy were calculated (3). In addition, comparison between
groups was performed using the unpaired t test and McNemar
Table 1 Total number of benign and malignant breast lesions
causing edema and the ﬁnal pathologic diagnosis.
Final pathologic diagnosis No. of cases Percentage (%)
Benign 11 30.5
Malignant 25 69.5
Total 36 100
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p< 0.001 was considered signiﬁcant.
3. Results
Our study included 34 female patients. Their age ranged from
29 to 80 years, the mean age is about 54.5 years and the med-
ian is 49.5.
Two patients had bilateral breast edema while thirty-two
patients had unilateral breast edema.
For better statistical analysis and more accurate results, we
considered each edematous breast with its ipsilateral axillary
lymph nodes as a unit (case), hence giving the total of 36
breasts or ‘‘cases’’.
Ten patients had underwent conservative breast surgery
and axillary evacuation while the rest of patients presented
with breast edema (±palpable mass) as their ﬁrst complaint.
Patients’ presentations varied as follows:
 12/36 patients were presenting with palpable lump as well as
the swollen breast.
 For 10/36 patients, breast edema was their ﬁrst presenta-
tion. 4/10 had history of MRM of the contra lateral breast
of more than two year duration.
 10/36 patients underwent conservative breast surgery and
axillary evacuation. 5/10 received and ended their
chemotherapy and radiotherapy cycles of more than 2 year
duration and one came prior to receiving the radiotherapy.
 4/36 patients received neoadjuvant chemotherapy on
follow-up.
All breast lesions detected by CEDM as well as radiologi-
cally suspicious axillary lymph nodes were diagnosed patho-
logically by means of surgery, excisional biopsy, skin punch
biopsy, true cut biopsy, or ﬁne needle aspiration cytology.
Cases that proved pathologically of inﬂammatory or post-
operative negative result were considered as benign for statis-
tical analysis.
Sensitivity and speciﬁcity were estimated taking the proba-
bility of malignancy exhibited as masses or micro-calciﬁc clus-
ters detected by MX, as well as the presence of
masses ± pathological axillary lymph nodes by ultrasound,
to be considered as positive results. Comparisons of sensitivity
and speciﬁcity between MX, US and CEDM were subse-
quently made.
Eight out of the thirty-six edematous breasts had multiple
lesions, diagnosed pathologically as multicentric invasive duct
carcinoma; one of which was a postconservative breast surgery
recurrence. Of all the multiple lesions detected, only the most
dominant or the largest was included in the statistical analysis.
Eleven out of thirty-six edematous breasts were diagnosed
pathologically as benign caused edema; including 7 post-
operative (±radiotherapy) edematous changes, one chronic
abscess, one chronic granulomatous mastitis and two acute
inﬂammatory lesions.
The remaining twenty-ﬁve were initiated by malignant
lesions; either due to primary malignant breast masses or sec-
ondary to metastasis to the axillary lymph nodes.
Three out of the ten post-operative edematous breasts
showed pathologically proven recurrence; one of them showed
multiple lesions (multicentric).The total numbers of benign and malignant caused breast
edema are shown in Table 1
Detailed description for the number and percentage for
each pathological diagnosis of breast edema causative lesion
is illustrated in Table 2.
3.1. Imaging ﬁndings
Mammography: All cases have a variable degree of breast
edema including diffuse increased parenchymal density, coarse
trabecular pattern and increased skin thickness.
Twenty cases showed positive mammographic ﬁndings in
the form of masses ± micro-calciﬁc clusters. Masses were
detected in 10 cases; 3/10 cases had multiple lesions. Masses
accompanied by micro-calciﬁc clusters were detected in 6 cases,
while increased density with micro-calciﬁc clusters was
detected in 4 cases. Dense suspicious axillary lymph nodes
were delineated in 2 cases only in addition to breast masses.
Patients according to mammographic examination were 16
benign and 20 malignant (considering negative as benign).
When considering dense irregular masses or micro-calciﬁc
clusters as malignant there were 20/36 (55%) edematous
breasts diagnosed as malignancy caused edema by digital
mammography, out of which 17/20 (85%) conﬁrmed to be
malignant by pathology (true positive) and 3/20 (15%) were
benign by pathology (false positive).
On the other hand 16/36 (45%) cases diagnosed as benign
by digital mammography, out of which 10/16 (62.5%) were
benign (true negative) by pathology, and 6/16 (37.5%) were
malignant by pathology (false negative) (Table 3).
The calculated sensitivity of digital mammography hence
was 74%, with a speciﬁcity of 77%. The PPV and NPV were
85%, and 62.5% respectively (Fig. 1).
Ultrasound Findings included a variable degree of skin
thickening and dilated intradermal lymphatic channels.
Masses were detected in 18 cases as follows: 14 cases show
irregular inﬁltrative hypoechoic masses, 2 well circumscribed
lesions and 2 complicated cysts.
Seven out of the 14 cases with irregular inﬁltrative masses
exhibited multiplicity (multicentric).
Pathologically enlarged Ipsilateral axillary lymph nodes
were detected in 22 cases, of which 2 showed globular conﬁg-
uration; with central preserved fatty hila (proved histologically
to be nonspeciﬁc inﬂammatory) while the others showed effa-
ced/lost fatty hila. Only one case showed multiple enlarged
axillary lymph nodes with irregular outline.
According to ultrasound examination there were 11 benign
and 25 malignant cases.
Three patients showed edematous features of the breast
without deﬁnite underlying breast lesions only enlarged axil-
lary lymph nodes with effaced/lost fatty hila proved patholog-
ically to be metastatic IDC. Of these, two gave history of
Table 2 Total number of cases with ﬁnal pathologic diagnosis
of breast edema causative lesion.
Final pathologic diagnosis No. of
cases
Percentage
rev. (%)
Invasive duct carcinoma grade II 19 53
Metastatic axillary Lymph nodes
(ductal carcinoma)
3 8
Invasive duct and Lobular carcinoma 3 8
Acute mastitis 2 6
Chronic abscess 1 3
Chronic granulomatous mastitis 1 3
Post therapeutic sequel 7 19
Total 36 100
Table 4 Shows analysis of false positive and false negative
entities with Ultrasound.
False diagnosis Pathologic diagnosis No. of cases
False negative 3
Invasive duct carcinoma 2
Mixed IDC & ILC 1
False positive 2
Post CBS scar tissue 2
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the third had the primary breast IDC mass in the contralateral
breast in addition to the presenting edematous breast (bilateral
breast edema).
Another case showed a plain edematous picture in the
absence of any underlying suspicious breast lesion, yet evident
ipsilateral enlarged nonspeciﬁc axillary lymph nodes, which in
turn proved to be periductal mastitis by skin punch biopsy.
On US, 25/36 cases diagnosed as malignant, of which 23
were veriﬁed as malignant (true positive), and two were benign
by pathology (false positive).
On the other hand, 11/36 were negative by US, of these,
eight were true negative and three false negative (Table 4).
The calculated sensitivity of ultrasonography was 88%,
with a speciﬁcity of 80%. The PPV and NPV were 92% and
73% respectively (Fig. 1).
3.2. CEDM enhancement (Table 5)
Enhancement was observed in 29/36 edematous breasts as
follows:
 Intense enhancement was observed in all malignant tumors;
23 were heterogeneous, 1 homogeneous (Fig. 4 (case 3)).
 Contrast uptake was also observed in 5 out of 6 benign
related breasts. edema: 3 ring patterns and 2 revealed dif-
fuse increased parenchymal enhancement.Table 3 Shows analysis of false positive and false negative
entities with digital mammography considering mass ± micro
calciﬁc clusters as positive results.
False diagnosis Pathologic diagnosis No. of
cases
False negative 6
Local recurrence post CBS 1
Metastatic axillary lymph nodes 3
Mixed IDC & ILC (Metastatic from
contralateral breast after MRM)
1
Invasive duct carcinoma 1
False positive 3
Post CBS scar tissue 2
Granulomatous mastitis 1 Enhancing axillary lymph nodes was observed in four cases;
one of which proved to be a metastatic axillary lymph node
causing the ipsilateral breast edema.
 Enhancement was absent in seven cases. In two cases, meta-
static axillary lymph nodes were the cause of the edema
which could not be detected by CEDM (false negative)
and one case of benign caused edema proved to be inﬂam-
matory periductal mastitis (Fig. 5 (case 4)) and four postop-
erative cases (Fig. 7 (case 6)).
When considering the different patterns of contrast uptake
identiﬁed in our study, noncontrast uptake and diffuse
parenchymal uptake were considered as benign, while intense
contrast uptake as malignant, with a gray zone of ring
enhancement observed as both benign and malignant lesions
as noted in one of our benign cases that show ring enhancing
lesions and proved to be caseating granulomatous mastitis
(Fig. 6 (case 5)).
There were 11/36 (31%) cases diagnosed as benign by
pathology, 9/11 (82%) of them were benign by contrast mam-
mography, 8 were (true negative) and one case was falsely
diagnosed as benign postoperative distortion yet later proved
to be recurrence (false negative). 2/11 (27%) were malignant
caused edema by contrast and by pathology proved to be
benign (false positive).
On the other hand 25/36 (69%) were diagnosed as malig-
nant by pathology, which in turn concurred with the CEDM
ﬁndings in twenty-two cases (61%) giving true positive
ﬁndings.
Three out of ten postoperative cases showed pathologically
proven recurrence (Fig. 8 (case 7)), one of them was multicen-
tric (Fig. 2 (case 1)).0.00%
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Fig. 1 Bar chart illustrates sensitivity and speciﬁcity of MX, US
and CEDM in characterization of causative lesion of breast
edema.
(A) (B) (C) (D)             
Fig. 2 (case 1): A female patient 47 year-old underwent left MRM, received chemotherapy and now presenting with right breast edema.
Digital mammogram Cranio-caudal (CC) and mediolateral oblique (MLO) views of right breast (A&B) showing diffuse parenchymal
edema with ill deﬁned densities. Contrast enhanced spectral mammography (CESM) CC & MLO (C&D) multicentric enhancing nodular
breast lesions can be clearly delineated. Pathology was mixed invasive ductal and invasive lobular carcinoma.
(A) (B) (C) (D) 
Fig. 3 (case 2): A female patient 48 year-old, complains of diffuse left breast swelling. Digital mammogram CC and MLO (A&B)
showing edematous breast with increased density with suspected nodular masses. CESM CC & MLO (C&D) showing multiple enhancing
central and UOQ masses. Pathology was left breast invasive ductal carcinoma (IDC) with apocrine features.
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logically in eight (22%) of our cases (Fig. 3 (case 2)).
The calculated sensitivity of dual energy contrast enhanced
digital mammography was 95%, speciﬁcity was 73%, while the
positive predictive value (PPV) and negative predictive value
(NPV) were 88% and 88% respectively (Fig. 1). Among the
eight patients with multicentric histologically proven lesions,
all were detected by MX (mammography) + CEDM (100%)
versus 3 (37.5%) and 7 (87.5%) detected by mammography
alone and ultrasound respectively.4. Discussion
Breast edema can be caused by a variety of pathologic pro-
cesses of benign or malignant diseases. It may occur with
inﬂammatory breast carcinoma, lymphatic obstruction, masti-
tis, lymphoma, post-operative and post-radiation changes or
systemic conditions such as congestive heart failure and
nephritic/nephrotic syndrome (1).
Initial mammography and breast ultrasound examination
are the routine investigative modalities utilized for breast
816 N.A.E. ElSaid et al.lesions. Unfortunately, the breast edema lowers the sensitivity
of the mammography and ultrasonography result frequently in
nonspeciﬁc ﬁndings. In many instances, MRI is done as a com-
plementary study that provides useful information about the
causative lesions (1).
Cancers and ﬁbro-glandular tissue show similar X-ray
absorption; therefore, tumor enhancement with a contrast
medium should improve cancer detection (4).
Contrast-enhanced digital mammography is a new breast
imaging technique that aims at demonstrating breast carci-
noma angiogenesis. Technical and clinical experience has been
acquired and encouraging results have been published during
the last few years on CEDM as an adjunct to mammography
(5).
Temporal subtraction was ﬁrst tested with an approach
similar to that of breast MRI. These studies have shown the
capability of CEDM to depict tumor angiogenesis in invasive
breast cancer and have demonstrated contrast uptake in most
malignant lesions. The main advantage of temporal subtrac-
tion is its ability to analyze the kinetics of time-enhancement
curves. Kinetic curve assessment using CEDM, however, has
failed to demonstrate clinical relevance. Both benign and
malignant breast tumors, evaluated by using a temporal
CEDM technique, have shown progressive enhancement.Table 5 CEDM Pattern of enhancement after contrast
injection in masses detected by mammography.
CEDM enhancement pattern No. of
cases
Percentage
(%)
Heterogeneous 23 64
Homogeneous 1 3
Ring enhancement 3 8
Diﬀuse parenchymal enhancement 2 6
No enhancement/no abnormal
enhancement
7 19
(A) (B)  
Fig. 4 (case 3): A female patient 39 year-old, complains of
diffuse left breast edema and lump. Digital mammogram MLO
(A) showing edematous breast with central and axillary increased
density. CESM MLO (B) showing multiple cystic lesions with an
enhancing soft tissue mass inﬁltrating one of the cysts (arrowed).
Pathology was left breast IDC.One hypothesis to explain this lack of washout in most cancers
depicted with CEDM is that, unlike MRI, CEDM is a two-
dimensional projection imaging technique and region-of-
interest evaluations are made in a column of breast tissue that
is the summation of enhancing tumor and enhancing sur-
rounding normal breast parenchyma (5).
Jong et al. (2003), have performed temporal CEDM on 22
patients with suspect abnormalities found on conventional
mammography or ultrasound. The results showed the ability
of temporal CEDM to show cancers and suggested a potential
to identify cancers in dense breasts (4). Another study carried
by Dromain et al. (2006) concluded from a 20-patient study
that temporal CEDM has the potential to depict angiogenesis.
The study was on patients with malignant ﬁndings only, and
detected contrast enhancement in 80% of the lesions.
A more extended temporal CEDM study by Diekmann
et al. (2007) performed on 75 patients with 85 lesions com-
pared the performance of conventional mammography alone
versus temporal CEDM as an adjunct to conventional mam-
mography. The results indicated an improvement in the sensi-
tivity and speciﬁcity when adding temporal CEDM to the
conventional mammography. However, several limitations
affect temporal CEDM: the long examination and breast com-
pression time contribute to patient discomfort and increase the
probability of patient motion, generating artifacts on the sub-
tracted images; moreover, only one view per breast can be
acquired for a single injection of contrast medium. In addition
to this, there has been no proof that the information provided
by the contrast agent uptake kinetics is clinically useful. Also
no correlation could be found between the contrast enhance-
ment pattern and the malignant nature of the lesion. Hence,
it appeared that the diagnostically relevant information was
mainly given by the morphology and intensity of the contrast
agent uptake (6).
In our study, CEDM examinations were performed using a
dual-energy technique.
One preliminary clinical study using the dual-energy tech-
nique has been published. Lewin and colleagues (7) examined
26 women (14 with malignant lesions and 12 with benign
lesions) scheduled for breast biopsy with a pre- and post-
contrast MLO acquisition. Twelve of the 13 invasive carcino-
mas demonstrated strong or moderate enhancement, and one
demonstrated weak enhancement. Five of these invasive can-
cers were not detected on conventional MX. Of the 12 benign
lesions, 10 demonstrated no enhancement and two demon-
strated weak enhancement on CEDM images. Lewin’s study
based on the dual-energy method showed enhancement in
92% of the malignant lesions and in 16.6% of the benign
lesions (7). No quantiﬁcation of the performance of the
method was performed in this study, because of the restricted
number of recruited patients (3).
Another extended dual energy CEDM performed by
Dromain et al. (2011) to assess the diagnostic accuracy of
CEDM as an adjunct to mammography versus mammography
alone and versus mammography plus ultrasound on 120
women with 142 suspect ﬁndings on mammography and/or
ultrasound underwent CEDM. There were 80 malignant, 50
benign and 3 pre-cancerous lesions (1 case of atypical hyper-
plasia and 2 cases of lobular carcinoma in situ). CEDM
Enhancement was observed in 74 out of 80 malignant lesions.
This study showed that sensitivity was higher for
MX+ CEDM than it was for MX (93% vs. 78%) with no loss
(D)             (A) (B) (C)
Fig. 5 (case 4): A female patient 44 year-old, complains of diffuse right breast edema, redness and hotness. Digital mammogram CC and
MLO (A&B) showing edematous breast with diffuse increased density. CESM CC & MLO (C&D) showing diffuse parenchymal
enhancement with no masses. Pathology was peri-ductal mastitis.
(A) (B) (C) (D)
Fig. 6 (case 5): A female patient 37 year-old, complains of left breast edema and lump. Digital mammogram CC and MLO (A&B)
showing edematous breast with increased retroareolar density. CESM CC & MLO (C&D) showing enhancing retroareolar area with ring
like or cystic changes seen within. Pathology was noncaseating granulomatous mastitis.
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detected by MX+ CEDM vs. 16 and 15 lesions by MX and
US respectively. Dromain, et al. (2011) conﬁrmed that the ini-
tial clinical results show that CEDM has better diagnostic
accuracy than mammography alone and combined mammog-
raphy and ultrasound (3).
In our study, as our inclusion criteria were limited to
women with edematous breasts, our results showed signiﬁcant
increase in sensitivity of CEDM compared to MX alone, as it
is well known that highly dense breast parenchyma alters the
mammographic sensitivity.
Thus concurring with most of the previously published
studies for CEDM, for example (3,8), who in turn stated thatthe increase in sensitivity of cancer detection with CEDM is
highly pronounced in dense breast parenchyma.
We have further demonstrated that by utilizing CEDM,
contrast agent uptake was noted in all pathologically proven
malignant lesions. Compared with mammography alone,
CEDM signiﬁcantly increased the sensitivity and the speci-
ﬁcity, thus allowing a signiﬁcant reduction in the false
negatives.
CEDM is similar in concept to enhanced breast MR imag-
ing and could potentially be applicable in situations in which
MR imaging is currently used. Such situations include detec-
tion of a primary breast cancer in a woman with a positive
axillary lymph node and determination of the extent of disease
(A) (B) (C) (D)
Fig. 7 (case 6): A female patient 52 year-old developed right breast edema after conservative breast surgery. Digital mammogram CC
and MLO (A&B) showing edematous breast with increased parenchymatous density and no deﬁnite lesions. CESM CC & MLO (C&D)
showing no abnormally enhancing areas. Pathology was scar tissue with no recurrence.
(A) (B) 
Fig. 8 (case 7): A female patient 49 year-old, underwent CBS
2 years ago for IDC, ended chemo and radiotherapy on follow-up.
Digital mammogram MLO (A) showing edematous breast with
central increased density. CESM MLO (B) showing central
enhancing soft tissue mass with evident intraductal extension
(arrowed). Pathology was recurrent IDC.
818 N.A.E. ElSaid et al.in cases of known cancer, as well as problem solving in cases of
mammographic ﬁndings that were not depicted in additional
mammograms or US scans (7).
In our study CEDM revealed to be a good negative test for
exclusion of the underlying breast lesions in edematous breasts
in cases of metastatic axillary lymph nodes, while being a good
positive test in delineation of masses obscured by condensed
parenchymal tissue. MX alone can detect abnormality in
20/25 malignant breast edema compared to 22/25 detected
by CEDM. Two of which were false negative cases owing to
edema caused by lymphatic obstruction secondary to nodal
metastasis.
Similarly, a study carried by Saad et al. (2012) at the
National Cancer Institute, Cairo University included 60patients with mammographically dense breast parenchyma,
of which 14 had edematous breast changes. They noted that
there was a signiﬁcant increase in the detection of lesions
and better assessment of the local extent of the disease in these
patients with breast edema using CEDM. Of the 14 cases with
edematous breast changes, CEDM placed 13 cases in the cor-
rect BI-RADS category versus 8 cases with MX alone. More
lesions were detected by CEDM than by MX alone or by
MX+US. CEDM allowed the diagnosis of
multifocal/multi-centric disease in 5 out of the 14 cases, versus
1 and 3 cases by MX alone and US respectively. They conclude
that sensitivity was higher for CEDM than it was for
MX+US (97.7% vs. 93.2%), while speciﬁcity for CEDM
was lower than it was for MX+US (50% vs. 75%) (9).
We have managed to demonstrate the level of accuracy of
CEDM in detection of multicentric lesions, as CEDM has
managed to depict all multicentric lesions in eight patients
which were conﬁrmed later by pathological analysis as IDC
lesions, thus giving a (100%) detection by MX+ CEDM, ver-
sus 3 (37.5%) and 7 (87.5%) detected by mammography alone
and ultrasound respectively.
In our study, the overall sensitivity of CEDM proved to be
95% vs. 88% for US, while speciﬁcity for CEDM was 73% vs.
80% for US.
Axillary lymphadenopathies are the single most important
prognostic factor for operable breast cancer. Ultrasound is
more accurate than both the physical examination and mam-
mography in identifying metastatic axillary lymph nodes (10).
Benign lymph nodes usually present regular, oval or strip
shape on the ultrasonic images, and hyperechoic medulla sur-
rounded by the hypoechoic cortex. Longitudinal/transverse
axis ratio (The L/T ratio) of the benign lymph nodes is usually
above 2. The L/T ratio of the malignant ones is commonly
below 2. In most of the malignant lymph nodes, the medulla
echo becomes narrow and sometimes disappears (11).
As the metastatic axillary lymph nodes are important fre-
quent causes of breast edema, utilizing ultrasound in our study
revealed a higher sensitivity for detection of axillary nodal
Contrast enhanced digital mammography: Is it useful in detecting lesions in edematous breast? 819pathology as well as higher speciﬁcity particularly in evalua-
tion of axillary lymph nodes regarding sonographic evidence
of malignant nodal invasion such as their morphological
changes as well as preservation or effacement of their hypere-
choic medulla.
In our study axillary nodal pathology was detected by US
in 22 cases, and 20/22 showed suspicious malignant invasion
which proved pathologically to be metastatic. However, only
2 cases showed suspicious criteria on MX alone, in comparison
with the delineation of abnormal enhancement of axillary LNs
in 4 cases, by CEDM.
CEDM could be used to monitor the response to
chemotherapy. Treatment for women presenting with locally
advanced breast cancer includes neoadjuvant chemotherapy
with a decrease in tumor size obtained in as many as 91% of
patients. Shrinkage or disappearance of the tumor after neoad-
juvant chemotherapy predicts a good outcome. CEDM with its
ability to demonstrate both morphology and tumor enhance-
ment could be beneﬁcial in the assessment of treatment
response. However, its accuracy of determination of the
chemotherapeutic response should be evaluated since underes-
timation of tumor response may be caused by the presence of
therapy-induced enhancing lesions, such as ﬁbrosis, necrosis
and inﬂammation (12).
Our study has shown that CEDM allowed an accurate size
evaluation of residual active tumoral tissue in two cases of
postneoadjuvant chemotherapy with available data of the his-
tological size of lesions after MRM.
As postulated by previous studies, CEDM can be used in
the assessment of residual and recurrent disease. Indeed, the
diagnosis of residual and recurrent disease is often difﬁcult
because of post-surgical and post-radiation changes (12).
This has been consistent with our ﬁndings, as CEDM has
been perceived as substantially aiding in differentiation of
recurrent enhancing tumoral tissue, from scar tissue in post-
operative edematous breasts, with higher speciﬁcity compared
to MX+US.
Advantages of contrast-enhanced digital mammography,
which may point to its potential for wider use, compared to
MRI, include its relatively low cost and it being less time con-
suming. The higher resolution guaranteed by the mammogra-
phy system used is another point in favor of contrast
mammography (8).
Dual-energy CEDM presents the unique ability to bring
functional information in bilateral examinations of the breast
with potentially only one contrast agent injection. It offers
an immediate availability in the mammography suite without
new appointment and without loss of time. Furthermore, no
special training of the technologist is needed for positioning
the patient and for the acquisition of images. Dual-energy
CEDM examination is well accepted by patients, pleased to
have a complete assessment without remaining questionable
ﬁndings at the end of the day. It is a fast imaging technique
that provides a direct correlation with conventional mammo-
grams. In addition, subtracted CEDM images are very easy
and fast to interpret by the radiologists and to understand
by the oncologist and the surgeons (13). CESM may also be
a useful guide for biopsy and accurately detects lesions in
mammographically dense breasts (14).5. Conclusion
Dual-energy contrast-enhanced digital mammography is a use-
ful technique in identiﬁcation of lesions in mammographically
dense edematous breasts and capable of demonstrating lesions
that are not visible by standard mammography. It serves as a
promising means of follow-up of cases presenting by edema
after conservative breast surgery and chemotherapy.
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